Abstract
Although Elvehjem et al. (1937) discovered that nicotinamide relieved the neurological symptoms of pellagra in dogs, and in spite of the discovery by Hankes and Elvehjem (1949) that nicotinamide or tryptophan reversed the neurological syndrome produced in rats by a diet high in phenylalanine, the importance of nicotinamide and related compounds in neurology remained dormant for almost two decades. The recent surge of interest in the effects of the tryptophan-kynurenine-nicotinamide pathway compounds in neurology (Stone and Connick, 1985) and the transport of these compounds through the blood-brain-barrier prompted a study of the transport of nicotinic acid or nicotinamide through the blood-brain barrier and a subsequent study of the rate of metabolism of these two compounds in the human brain in various neurological disease states.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Elvehjem, C.A., Madden, R.J., Strong, F.M., and Wollen, D.W., 1937, Relation of nicotinic acid and nicotinic acid amide to canine black tongue, J. Am. Chem. Soc., 59: 1767–1768.
Hankes, L.V., and Elvehjem, C.A., 1949, A nervous syndrome produced with phenylalanine and methionine, Proc. Soc. Exp. Biol. Med., 72: 349–351.
Machulla, H.J., Laufer, P., and Stoecklin, G., 1976, Radioanalytical quality control of 11C, 18F and 123I labelled compounds and radiopharmaceuticals, Radioanal. Chem., 32: 381–400.
Patlak, C.S., and Blasberg, R.G., 1985, Graphical evaluation of blood to brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab., 5: 584–590.
Rota, E., Herzog, H., Schmid, A., Holte, S., and Feinendegen, L.E., 1988, Performance of machine parameters and its influence on metabolic data using the PET-scanner Pc-4096-15WB, J. Nucl. Med., 29: 877.
Stone, T.W., and Connick, J.H., 1985, Quinolinic acid and other kynurenines in the central nervous system, Neuroscience, 15: 597–617.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Hankes, L.V. et al. (1991). Effect of Huntington’s and Alzheimer’s Diseases on the Transport of Nicotinic Acid or Nicotinamide Across the Human Blood-Brain Barrier. In: Schwarcz, R., Young, S.N., Brown, R.R. (eds) Kynurenine and Serotonin Pathways. Advances in Experimental Medicine and Biology, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5952-4_91
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5952-4_91
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5954-8
Online ISBN: 978-1-4684-5952-4
eBook Packages: Springer Book Archive